FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3018444979> ?p ?o ?g. }

• W3018444979 endingPage "21" @default.
• W3018444979 startingPage "1" @default.
• W3018444979 abstract "Objective . The drug efficacy may differ among different statins, and evidence from head-to-head comparisons is sparse and inconsistent. The study is aimed at comparing the lipid-lowering/increasing effects of 7 different statins in patients with dyslipidemia, cardiovascular diseases, or diabetes mellitus by conducting systematic review and network meta-analyses (NMA) of the lipid changes after certain statins’ use. Methods . In this study, we searched four electronic databases for randomized controlled trials (RCTs) published through February 25, 2020, comparing the lipid-lowering efficacy of no less than two of the included statins (or statin vs. placebo). Three reviewers independently extracted data in duplicate. Firstly, mixed treatment overall comparison analyses, in the form of frequentist NMAs, were conducted using STATA 15.0 software. Then, subgroup analyses were conducted according to different baseline diseases. At last, sensitivity analyses were conducted according to age and follow-up duration. The trial was registered with PROSPERO (number CRD42018108799 ). Results . As a result, seven statin monotherapy treatments in 50 studies (51956 participants) were used for the analyses. The statins included simvastatin (SIM), fluvastatin (FLU), atorvastatin (ATO), rosuvastatin (ROS), lovastatin (LOV), pravastatin (PRA), and pitavastatin (PIT). In terms of LDL-C lowering, rosuvastatin ranked 1 st with a surface under cumulated ranking (SUCRA) value of 93.1%. The comparative treatment efficacy for LDL-C lowering was ROS>ATO>PIT>SIM>PRA>FLU>LOV>PLA. All of the other ranking and NMA results were reported in SUCRA plots and league tables. Conclusions . According to the NMAs, it can be concluded that rosuvastatin ranked 1 st in LDL-C, ApoB-lowering efficacy and ApoA1-increasing efficacy. Lovastatin ranked 1 st in TC- and TG-lowering efficacy, and fluvastatin ranked 1 st in HDL-C-increasing efficacy. The results should be interpreted with caution due to some limitations in our review. However, they can provide references and evidence-based foundation for drug selection in both statin monotherapies and statin combination therapies." @default.
• W3018444979 created "2020-05-01" @default.
• W3018444979 creator A5004150390 @default.
• W3018444979 creator A5011496776 @default.
• W3018444979 creator A5011694644 @default.
• W3018444979 creator A5018758094 @default.
• W3018444979 creator A5019958020 @default.
• W3018444979 creator A5033963611 @default.
• W3018444979 creator A5037101612 @default.
• W3018444979 creator A5041509417 @default.
• W3018444979 creator A5056053058 @default.
• W3018444979 creator A5062487012 @default.
• W3018444979 creator A5084662844 @default.
• W3018444979 date "2020-04-27" @default.
• W3018444979 modified "2023-10-18" @default.
• W3018444979 title "Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials" @default.
• W3018444979 cites W1480862800 @default.
• W3018444979 cites W1509852289 @default.
• W3018444979 cites W1600643215 @default.
• W3018444979 cites W1617328014 @default.
• W3018444979 cites W1643140812 @default.
• W3018444979 cites W1799873623 @default.
• W3018444979 cites W1979019930 @default.
• W3018444979 cites W1983634599 @default.
• W3018444979 cites W1987882217 @default.
• W3018444979 cites W1989337172 @default.
• W3018444979 cites W1995243968 @default.
• W3018444979 cites W1996994490 @default.
• W3018444979 cites W1997668869 @default.
• W3018444979 cites W2000218345 @default.
• W3018444979 cites W2001712808 @default.
• W3018444979 cites W2006106395 @default.
• W3018444979 cites W2014725150 @default.
• W3018444979 cites W2019939987 @default.
• W3018444979 cites W2022805973 @default.
• W3018444979 cites W2024462363 @default.
• W3018444979 cites W2030475349 @default.
• W3018444979 cites W2031185570 @default.
• W3018444979 cites W2037593179 @default.
• W3018444979 cites W2043421666 @default.
• W3018444979 cites W2050993113 @default.
• W3018444979 cites W2054176199 @default.
• W3018444979 cites W2057744032 @default.
• W3018444979 cites W2058323492 @default.
• W3018444979 cites W2059212845 @default.
• W3018444979 cites W2059959548 @default.
• W3018444979 cites W2060879673 @default.
• W3018444979 cites W2063274643 @default.
• W3018444979 cites W2064892995 @default.
• W3018444979 cites W2074207405 @default.
• W3018444979 cites W2075025181 @default.
• W3018444979 cites W2082390372 @default.
• W3018444979 cites W2085803274 @default.
• W3018444979 cites W2090231128 @default.
• W3018444979 cites W2097024748 @default.
• W3018444979 cites W2100800328 @default.
• W3018444979 cites W2101094196 @default.
• W3018444979 cites W2106195278 @default.
• W3018444979 cites W2107295258 @default.
• W3018444979 cites W2117872028 @default.
• W3018444979 cites W2127933204 @default.
• W3018444979 cites W2132064529 @default.
• W3018444979 cites W2133184701 @default.
• W3018444979 cites W2134107470 @default.
• W3018444979 cites W2134826755 @default.
• W3018444979 cites W2142822151 @default.
• W3018444979 cites W2144625636 @default.
• W3018444979 cites W2148939671 @default.
• W3018444979 cites W2150948948 @default.
• W3018444979 cites W2158793918 @default.
• W3018444979 cites W2159111147 @default.
• W3018444979 cites W2159275221 @default.
• W3018444979 cites W2160313369 @default.
• W3018444979 cites W2166910397 @default.
• W3018444979 cites W2170892587 @default.
• W3018444979 cites W2316863796 @default.
• W3018444979 cites W2728308253 @default.
• W3018444979 cites W2746257371 @default.
• W3018444979 cites W2780938782 @default.
• W3018444979 cites W2793626651 @default.
• W3018444979 cites W2840365123 @default.
• W3018444979 cites W2899611489 @default.
• W3018444979 cites W2900034165 @default.
• W3018444979 cites W2900848740 @default.
• W3018444979 cites W2903634378 @default.
• W3018444979 cites W2916492843 @default.
• W3018444979 cites W2944199520 @default.
• W3018444979 cites W2964727817 @default.
• W3018444979 cites W560773721 @default.
• W3018444979 doi "https://doi.org/10.1155/2020/3987065" @default.
• W3018444979 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7201823" @default.
• W3018444979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32411300" @default.
• W3018444979 hasPublicationYear "2020" @default.
• W3018444979 type Work @default.
• W3018444979 sameAs 3018444979 @default.
• W3018444979 citedByCount "21" @default.
• W3018444979 countsByYear W30184449792020 @default.
• W3018444979 countsByYear W30184449792021 @default.

• next